Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 276, Issue 1, pp 267–272 | Cite as

Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?

  • Paola Vincenza Sartori
  • Alberto Maria SaibeneEmail author
  • Ennio Leopaldi
  • Marco Boniardi
  • Edoardo Beretta
  • Samuele Colombo
  • Emanuela Morenghi
  • Juliana Pauna
  • Loredana De Pasquale
Short Communication

Abstract

Purpose

Intraoperative PTH testing (IOPTH) in treatment of primary hyperparathyroidism (PH) is debated. Some authors advise against IOPTH in patients with concordant preoperative imaging undergoing focused parathyroidectomy. This study aims to compare focused parathyroidectomy success rates with and without IOPTH in patients with concordant preoperative imaging.

Methods

Retrospective cohort study involving 599 consecutive patients underwent surgery for PH from 2012 to 2017. Patients with discordant preoperative imaging were excluded. 426 patients underwent focused parathyroidectomy (214 patients without IOPTH and 212 with IOPTH) and were considered for the statistical analysis. In case of insufficient IOPTH decay (less than 50%), a bilateral exploration was carried out.

Results

The IOPTH group and the non-IOPTH group were similar for demographics and preoperative PTH and calcaemia. 413 patients were cured and disease persistence rates between groups were not significantly different (p > 0.05).

Conclusions

Although further testing and randomized-controlled trials are required to validate our findings, our data show that IOPTH does not seem to improve the outcome in patients with concordant preoperative imaging undergoing focused parathyroidectomy.

Keywords

PTH level Primary hyperparathyroidism Parathyroid hormone Parathyroidectomy Minimally invasive surgery 

Notes

Funding

The authors did not receive any grant or financial support of sorts for this study. They have no financial disclosures to make.

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interests pertaining this manuscript.

References

  1. 1.
    Gioviale MC, Damiano G, Altomare R, Maione C, Buscemi S, Buscemi G, Lo Monte AI (2016) Intraoperative measurement of parathyroid hormone: a Copernican revolution in the surgical treatment of hyperparathyroidism. Int J Surg 28S1:S99–S102CrossRefGoogle Scholar
  2. 2.
    Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W (2009) Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 394:843–849CrossRefGoogle Scholar
  3. 3.
    Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B (2007) A “defined baseline” in PTH monitoring increases surgical success in patients with multiple gland disease. Surger 142:398–404CrossRefGoogle Scholar
  4. 4.
    Irvin GL, Solorzano CC, Carneiro DM (2004) Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28:1287–1292CrossRefGoogle Scholar
  5. 5.
    Lombardi CP, Raffaelli M, Traini E, Di Stasio E, Carrozza C, De Crea C, Zuppi C, Bellantone R (2008) Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch Surg 393:639–645CrossRefGoogle Scholar
  6. 6.
    Mozzon M, Mortier PE, Jacob PM, Soudan B, Boersma AA, Proye CA (2004) Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine PTH measurement the morning after. Ann Surg 240:949–954CrossRefGoogle Scholar
  7. 7.
    Carter AB, Howanitz PJ (2003) Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 127:1424–1442Google Scholar
  8. 8.
    Khan AA, Khatun Y, Walker A, Jimeno J, Hubbard JG (2015) Role of intraoperative PTH monitoring and surgical approach in primary hyperparathyroidism. Ann Med Surg (Lond) 4:301–305CrossRefGoogle Scholar
  9. 9.
    Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, Gionfriddo MR, Al Nofal A, Brito JP, Erwin P, Richards M, Wermers R, Montori VM (2016) Outcomes of parathyroidectomy in patients with primary hyperparathyroidism: a systematic review and meta-analysis. World J Surg 40:2359–2377CrossRefGoogle Scholar
  10. 10.
    Locchi F, Cavalli T, Giudici F, Brandi ML, Tonelli F (2014) Intraoperative PTH monitoring: a new approach based on the identification of the “true” time origin of the decay curve. Endocr J 61:239–247CrossRefGoogle Scholar
  11. 11.
    Lew JI, Solorzano CC (2009) Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am 89:1205–1225CrossRefGoogle Scholar
  12. 12.
    Di Stasio E, Carrozza C, Pio Lombardi C, Raffaelli M, Traini E, Bellantone R, Zuppi C (2007) Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem 40:595–603CrossRefGoogle Scholar
  13. 13.
    Calò PG, Pisano G, Loi G, Medas F, Barca L, Atzeni M, Nicolosi A (2013) Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement. BMC Surg 13:36CrossRefGoogle Scholar
  14. 14.
    Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG (2004) Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg 28:187–192CrossRefGoogle Scholar
  15. 15.
    Mihai R, Palazzo FF, Gleeson FV, Sadler GP (2007) Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg 94:42–47CrossRefGoogle Scholar
  16. 16.
    Nair CG, Babu MJ, Jacob P, Menon R, Mathew J (2016) Is intraoperative parathyroid hormone monitoring necessary in symptomatic primary hyperparathyroidism with concordant imaging? Indian J Endocrinol Metab 20:512–516CrossRefGoogle Scholar
  17. 17.
    Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) European Society of Endocrine Surgery. Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764CrossRefGoogle Scholar
  18. 18.
    Badii B, Staderini F, Foppa C, Tofani L, Skalamera I, Fiorenza G, Qirici E, Cianchi F, Perigli G (2017) Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism. Head Neck 39:241–246CrossRefGoogle Scholar
  19. 19.
    Wharry LI, Yip L, Armstrong MJ, Virji MA, Stang MT, Carty SE, McCoy KL (2014) The final intraoperative parathyroid hormone level: how low should it go? World J Surg 38:558–563CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Paola Vincenza Sartori
    • 1
  • Alberto Maria Saibene
    • 2
    Email author
  • Ennio Leopaldi
    • 3
  • Marco Boniardi
    • 4
  • Edoardo Beretta
    • 5
  • Samuele Colombo
    • 6
  • Emanuela Morenghi
    • 7
  • Juliana Pauna
    • 4
  • Loredana De Pasquale
    • 2
  1. 1.Surgery DepartmentDesio HospitalDesioItaly
  2. 2.Thyroid and Parathyroid Surgery Service, Otolaryngology Unit, San Paolo Hospital, Department of Health SciencesUniversità degli Studi di MilanoMilanItaly
  3. 3.Surgery DepartmentIGEA Private HospitalMilanItaly
  4. 4.General and Minimally Invasive Surgery DepartmentNiguarda HospitalMilanItaly
  5. 5.Endocrine Surgery UnitSan Raffaele HospitalMilanItaly
  6. 6.Endocrine Surgery CenterAuxologico InstituteMedaItaly
  7. 7.Biostatistics UnitHumanitas Clinical InstituteMilanItaly

Personalised recommendations